Clinical Trial Update: A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of cryopreserved OTL-200 for Metachromatic Leukodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metachromatic Leukodystrophy

Drugs mentioned

• OTL-200

Snippet

Sponsor: Orchard Therapeutics | Conditions: Lysosomal Storage Disease, Metachromatic Leukodystrophy | Phase 2 | Status: COMPLETED